Weekly Digest – February 2026 Weekly Digest – February 2026 14 February 2026: Alphamab Oncology announces the first patient dosed in a phase 3 clinical study for colorectal cancer of biparatopic HER2-targeting ADC JSKN003 Alphamab Oncology announced that the first […]
Weekly Digest – February 2026 Weekly Digest – February 2026 17 February 2026: BostonGene announces strategic collaboration with Daiichi Sankyo to accelerate drug development through AI-driven multimodal analytics BostonGene announced a strategic collaboration with Daiichi Sankyo to integrate AI-driven multimodal […]
Weekly Digest – February 2026 Weekly Digest – February 2026 19 February 2026: Affibody signs Letter of Intent with SHINE Technologies for supply of Lutetium-177 Affibody announced that it has signed a Letter of Intent with SHINE Technologies to secure […]
